COVID-19 Detection Tests in Different Body Fluids
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04473352|
Recruitment Status : Not yet recruiting
First Posted : July 16, 2020
Last Update Posted : August 13, 2020
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||80 participants|
|Target Follow-Up Duration:||12 Months|
|Official Title:||Diagnostic Accuracy of COVID-19 Detection Tests in Different Body Fluids of Infected Men and Concordance With Viral Cultures|
|Estimated Study Start Date :||September 2020|
|Estimated Primary Completion Date :||September 2021|
|Estimated Study Completion Date :||November 2021|
Patients with suspected acute viral status for COVID 19 will be invited to participate in the identification of the first symptoms. The diagnosis of COVID-19 will be confirmed according to the determinations of the MS through the reaction of qRT-PCR in the nasopharynx swab. Patients will undergo multiple collections of biological material including blood, saliva, semen, and urine. Each patient will be subjected to serial sample collections. The samples will be processed and analyzed for the presence of viral RNA. Patients with 2 consecutive negative samples did not need to perform subsequent collections.
- Accuracy of Covid19 Detection [ Time Frame: September 2021 ]Numerical variables will be described by measurements of central tendency (mean or median) and the respective dispersion measurements. Categorical variables will be described by their absolute values, percentages, or proportions. To compare the differences of continuous variables, we will use the Student t-test or the Mann-Whitney test. For comparison of categorical data, we will use the chi-square test. Univariable and multivariable analyses will be performed to identify predictors of COVID-19 detection.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04473352
|Contact: Ricardo Reges, PhD||+55 85 firstname.lastname@example.org|
|Contact: Eduardo P Miranda, PhD||+55 85 email@example.com|
|Principal Investigator:||Ricardo Reges, PhD||Nucleo de Pesquisa e Desenvolvimento de Medicamentos|